These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Changes in the components of the animal fibrinolytic system induced by the action of physiological activators and enzymes of fungal origin]. Andreenko GV; Serebriakova TN; Shimonaeva EE; Liutova LV; Karabasova MA Nauchnye Doki Vyss Shkoly Biol Nauki; 1983; (3):51-4. PubMed ID: 6342687 [TBL] [Abstract][Full Text] [Related]
6. [New thrombolytic agents in myocardial infarction]. Charbonnier B; Lang M; Brochier M Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222 [TBL] [Abstract][Full Text] [Related]
7. Tissue-type plasminogen activator (t-PA) and single chain urokinase-type plasminogen activator (scu-PA): potential for fibrin-specific thrombolytic therapy. Collen D Prog Hemost Thromb; 1986; 8():1-18. PubMed ID: 3104986 [No Abstract] [Full Text] [Related]
8. Clinical pharmacology of the thrombolytic enzyme preparation brinase. Frisch EP Semin Thromb Hemost; 1989 Jul; 15(3):341-6. PubMed ID: 2688105 [No Abstract] [Full Text] [Related]
9. [Thrombolytic effect of urokinase upon various methods of administration into the body]. Andreenko GV; Serebriakova TN; Podorol'skaia LV; Afanasenko GA; Liaginskiĭ AV; Raevskaia AK Vopr Med Khim; 1992; 38(1):44-6. PubMed ID: 1441294 [TBL] [Abstract][Full Text] [Related]
10. An assessment of regional versus systemic thrombolytic treatment of peripheral and coronary artery thrombosis. Marder VJ; Francis CW Prog Hemost Thromb; 1984; 7():325-56. PubMed ID: 6241729 [No Abstract] [Full Text] [Related]